# OnCo record blacksmith-medicines (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/blacksmith-medicines/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "blacksmith-medicines" ;
  schema:name "Blacksmith Medicines"@en ;
  schema:alternateName "Blacksmith Medicines, Inc."@en ;
  schema:description "Blacksmith Medicines designs drugs against metal-containing enzymes. In cancer it is developing inhibitors of FEN1, a DNA-repair enzyme, to combine with PARP inhibitors in ovarian cancer, and the work is in the laboratory."@en ;
  schema:url <https://onco.cc/companies/blacksmith-medicines/>, <https://blacksmithmedicines.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://blacksmithmedicines.com/>, <https://blacksmithmedicines.com/pipeline-targets/>, <https://reporter.nih.gov/project-details/11410176> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/ovarian/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/>, <https://onco.cc/fronts/drug-discovery/> ;
  onco:technologies <https://onco.cc/technologies/synthetic-lethality-approaches/>, <https://onco.cc/technologies/parp-inhibitor/> .